Through its versatile bioprinting platforms which can impact tissue engineering, organ-on-a-chip development, and pharmaceutical, Allevi empowers scientists to design and create complex tissue structures efficiently, advancing research in regenerative medicine and biomedical innovation.
Allevi's accessible and versatile platforms simplify biofabrication, accelerating biomedical innovation. This aligns with Space Capital's investment thesis of advancing cutting-edge technology that supports groundbreaking research and fosters scalable solutions in critical industries like healthcare and life sciences.